News & Events

News

Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who, like us, believe noninvasive brain stimulation harnesses the brain's own healing power—neuroplasticity. Nexstim is helping patients—and their families—get back the life they feared they had lost.

Customers and Trade

Research and Development

Delve Psychiatry in Nevada, United States Orders Nexstim NBS 5+ System

Nexstim Receives NBS 6 Order from University Hospital in California

Distributor Orders Two Nexstim NBS 5 Systems

Finnish University Hospital Orders Nexstim NBS System 5

Nexstim Receives an Upgrade Order from a German University Hospital

US Customer Orders Nexstim NBS System 5

Nexstim Plc’s New Shares Have Been Registered with the Finnish Trade Register

Nexstim Plc: Managers’ Transactions, Forss

Nexstim Plc: Managers’ Transactions, Niemistö

Nexstim Plc: Managers’ Transactions, Weckroth

The Board of Directors of Nexstim Plc has decided on a directed share issue and issuance of special rights to Brainlab AG and on the conversion of a convertible bond

Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement and agreeing on a maximum of EUR 5,095,000 equity investment into Nexstim